TG Therapeutics (TGTX) Quick Ratio: History & Chart

TG Therapeutics, Inc.(TGTX)

Biotechnology · Morrisville, NY

$52.19-1.72 (-3.19%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About TG Therapeutics, Inc.

Based in New York City and established in 1993, TG Therapeutics, Inc. is a biopharmaceutical company that has advanced to the commercial stage. Its core mission revolves around the acquisition, advancement, and marketing of novel therapeutic solutions. The company's focus areas specifically include B-cell related cancers (malignancies) and various autoimmune disorders. Among its significant investigational therapeutic candidates is Ublituximab, a distinctive glycoengineered monoclonal antibody currently undergoing evaluation. It targets B-cell non-Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and the relapsing forms of multiple sclerosis. Another compound in its pipeline is Umbralisib, an orally administered inhibitor designed to block PI3K-delta and CK1-epsilon enzymes. This treatment is being investigated for its effectiveness against CLL, marginal zone lymphoma, and follicular lymphoma. TG Therapeutics is also developing Cosibelimab, an IgG1 human monoclonal antibody that functions by binding to programmed death-ligand 1 (PD-L1) and subsequently preventing its interaction with PD-1 and B7.1 receptors. Furthermore, the company is advancing TG-1701, an oral, covalently-bound Bruton's tyrosine kinase (BTK) inhibitor, notably more selective for BTK compared to ibrutinib in laboratory screenings. Completing this clinical-stage portfolio is TG-1801, a bispecific antibody engineered to simultaneously target CD47 and CD19. Beyond its clinical-stage assets, the company possesses various licensed preclinical programs, including those addressing BET, interleukin-1 receptor associated kinase-4, and GITR. To enhance its research and development capabilities, TG Therapeutics has forged collaboration agreements with entities such as Checkpoint Therapeutics, Inc., Jiangsu Hengrui Medicine Co., Novimmune SA, Ligand Pharmaceuticals Incorporated, and Jubilant Biosys. The company also maintains strategic alliances with partners including LFB Biotechnologies S.A.S, GTC Biotherapeutics, LFB/GTC LLC, Ildong Pharmaceutical Co. Ltd., and Rhizen Pharmaceuticals, S A.

Morrisville, NY

399 employees

www.tgtherapeutics.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Michael S. Weiss

View full financials

TGTX Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

3.72

QUICK RATIO (ACID-TEST) AVG TTM

3.59

QUICK RATIO (ACID-TEST) AVG 3Y

3.71

QUICK RATIO (ACID-TEST) AVG 5Y

3.93

QUICK RATIO (ACID-TEST) AVG 10Y

3.64

QUICK RATIO (ACID-TEST) AVG 15Y

4.59

QUICK RATIO (ACID-TEST) AVG 20Y

3.58

CURRENT VS TTM AVG

+3.40%

CURRENT VS 3Y AVG

+0.22%

CURRENT VS 5Y AVG

-5.40%

CURRENT VS 10Y AVG

+2.02%

CURRENT VS 15Y AVG

-19.09%

CURRENT VS 20Y AVG

+3.78%

SECTOR MEDIAN · HEALTHCARE

3.35

median of 870 covered companies

CURRENT VS SECTOR MEDIAN

+10.76%

vs the sector median at left

NAME	MARKET CAP	QUICK RATIO (ACID-TEST)	TTM	3Y	5Y
TG Therapeutics, Inc. (TGTX)	$7.99B	3.72	3.59	3.71	3.93
Praxis Precision Medicines, Inc. (PRAX)vs ›	$7.81B	15.73	10.50	7.40	9.39
Caris Life Sciences, Inc. (CAI)vs ›	$7.76B	4.88	4.46	3.60	3.01
Cytokinetics, Incorporated (CYTK)vs ›	$7.63B	6.66	5.35	6.55	8.14
HealthEquity, Inc. (HQY)vs ›	$7.61B	2.99	3.17	3.50	3.09
Hinge Health, Inc. (HNGE)vs ›	$7.61B	1.30	1.86	2.18	2.18
Oscar Health, Inc. (OSCR)vs ›	$8.38B	1.08	0.93	1.08	1.24
Ionis Pharmaceuticals, Inc. (IONS)vs ›	$7.31B	7.72	6.12	6.28	6.38
Arrowhead Pharmaceuticals, Inc. (ARWR)vs ›	$8.67B	5.90	5.80	4.66	4.84
Kymera Therapeutics, Inc. (KYMR)vs ›	$8.72B	N/A	9.00	7.15	6.04

NAME

MARKET CAP

QUICK RATIO (ACID-TEST)

TTM

TG Therapeutics, Inc. (TGTX)

$7.99B

3.72

3.59

3.71

3.93

Praxis Precision Medicines, Inc. (PRAX)vs ›

$7.81B

15.73

10.50

7.40

9.39

Caris Life Sciences, Inc. (CAI)vs ›

$7.76B

4.88

4.46

3.60

3.01

Cytokinetics, Incorporated (CYTK)vs ›

$7.63B

6.66

5.35

6.55

8.14

HealthEquity, Inc. (HQY)vs ›

$7.61B

2.99

3.17

3.50

3.09

Hinge Health, Inc. (HNGE)vs ›

$7.61B

1.30

1.86

2.18

Oscar Health, Inc. (OSCR)vs ›

$8.38B

1.08

0.93

1.08

1.24

Ionis Pharmaceuticals, Inc. (IONS)vs ›

$7.31B

7.72

6.12

6.28

6.38

Arrowhead Pharmaceuticals, Inc. (ARWR)vs ›

$8.67B

5.90

5.80

4.66

4.84

Kymera Therapeutics, Inc. (KYMR)vs ›

$8.72B

N/A

9.00

7.15

6.04

Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for TG Therapeutics, Inc. (TGTX)?

The quick ratio (acid-test) for TGTX stock is 3.72.

Is TG Therapeutics, Inc.'s quick ratio (acid-test) high or low?

The quick ratio (acid-test) of 3.72 is in line with its 5-year average of 3.93, around the middle of its 5-year range (2.45–5.20).

What is the TTM average quick ratio (acid-test) for TG Therapeutics, Inc. (TGTX)?

The TTM average quick ratio (acid-test) for TGTX stock is 3.59.

What is the 3Y average quick ratio (acid-test) for TG Therapeutics, Inc. (TGTX)?

The 3Y average quick ratio (acid-test) for TGTX stock is 3.71.

What is the 5Y average quick ratio (acid-test) for TG Therapeutics, Inc. (TGTX)?

The 5Y average quick ratio (acid-test) for TGTX stock is 3.93.

What is the 10Y average quick ratio (acid-test) for TG Therapeutics, Inc. (TGTX)?

The 10Y average quick ratio (acid-test) for TGTX stock is 3.64.

What is the 15Y average quick ratio (acid-test) for TG Therapeutics, Inc. (TGTX)?

The 15Y average quick ratio (acid-test) for TGTX stock is 4.59.

What is the 20Y average quick ratio (acid-test) for TG Therapeutics, Inc. (TGTX)?

The 20Y average quick ratio (acid-test) for TGTX stock is 3.58.

DATE	QUICK RATIO (ACID-TEST)
2026-06-30	3.72
2026-03-31	5.12
2025-12-31	3.29
2025-09-30	2.89
2025-06-30	2.96
2025-03-31	3.04
2024-12-31	5.03
2024-09-30	3.91
2024-06-30	2.83
2024-03-31	2.84
2023-12-31	5.18
2023-09-30	4.95
2023-06-30	2.45
2023-03-31	2.50
2022-12-31	3.16
2022-09-30	5.02
2022-06-30	4.68
2022-03-31	4.43
2021-12-31	5.06
2021-09-30	4.24
2021-06-30	5.20
2021-03-31	5.78
2020-12-31	6.99
2020-09-30	3.35
2020-06-30	4.16
2020-03-31	1.39
2019-12-31	1.77
2019-09-30	1.00
2019-06-30	1.69
2019-03-31	1.72
2018-12-31	1.78
2018-09-30	2.44
2018-06-30	3.44
2018-03-31	3.30
2017-12-31	3.05
2017-09-30	4.93
2017-06-30	4.21
2017-03-31	5.60
2016-12-31	2.68
2016-09-30	3.63
2016-06-30	3.90
2016-03-31	6.70
2015-12-31	9.77
2015-09-30	9.79
2015-06-30	10.08
2015-03-31	11.10
2014-12-31	15.45
2014-09-30	7.59
2014-06-30	19.76
2014-03-31	27.09
2013-12-31	7.20
2013-09-30	8.91
2013-06-30	4.09
2013-03-31	7.19
2012-12-31	8.34
2012-09-30	6.48
2012-06-30	8.71
2012-03-31	17.19
2011-12-31	6.12
2011-09-30	0.21
2011-06-30	0.16
2011-03-31	0.27
2010-12-31	0.26
2010-09-30	0.30
2010-06-30	0.37
2010-03-31	0.32
2009-12-31	0.10
2009-09-30	0.15
2009-06-30	0.29
2009-03-31	0.80
2008-12-31	0.59
2008-09-30	0.06
2008-06-30	0.49
2008-03-31	0.77
2007-12-31	0.46
2007-09-30	1.25
2007-06-30	2.03
2007-03-31	4.19
2006-12-31	1.69
2006-09-30	3.65
2006-06-30	3.40
2006-03-31	4.05
2005-12-31	6.62
2005-09-30	7.13
2005-06-30	1.66
2005-03-31	3.20
2004-12-31	4.57
2004-09-30	5.04
2004-06-30	14.24
2004-03-31	13.09
2003-12-31	8.06
2003-09-30	0.35
2003-06-30	0.49
2003-03-31	1.13
2002-12-31	0.30
2002-09-30	0.91

DATE

QUICK RATIO (ACID-TEST)

2026-06-30

3.72

2026-03-31

5.12

2025-12-31

3.29

2025-09-30

2.89

2025-06-30

2.96

2025-03-31

3.04

2024-12-31

5.03

2024-09-30

3.91

2024-06-30

2.83

2024-03-31

2.84

2023-12-31

5.18

2023-09-30

4.95

2023-06-30

2.45

2023-03-31

2.50

2022-12-31

3.16

2022-09-30

5.02

2022-06-30

4.68

2022-03-31

4.43

2021-12-31

5.06

2021-09-30

4.24

2021-06-30

5.20

2021-03-31

5.78

2020-12-31

6.99

2020-09-30

3.35

2020-06-30

4.16

2020-03-31

1.39

2019-12-31

1.77

2019-09-30

1.00

2019-06-30

1.69

2019-03-31

1.72

2018-12-31

1.78

2018-09-30

2.44

2018-06-30

3.44

2018-03-31

3.30

2017-12-31

3.05

2017-09-30

4.93

2017-06-30

4.21

2017-03-31

5.60

2016-12-31

2.68

2016-09-30

3.63

2016-06-30

3.90

2016-03-31

6.70

2015-12-31

9.77

2015-09-30

9.79

2015-06-30

10.08

2015-03-31

11.10

2014-12-31

15.45

2014-09-30

7.59

2014-06-30

19.76

2014-03-31

27.09

2013-12-31

7.20

2013-09-30

8.91

2013-06-30

4.09

2013-03-31

7.19

2012-12-31

8.34

2012-09-30

6.48

2012-06-30

8.71

2012-03-31

17.19

2011-12-31

6.12

2011-09-30

0.21

2011-06-30

0.16

2011-03-31

0.27

2010-12-31

0.26

2010-09-30

0.30

2010-06-30

0.37

2010-03-31

0.32

2009-12-31

0.10

2009-09-30

0.15

2009-06-30

0.29

2009-03-31

0.80

2008-12-31

0.59

2008-09-30

0.06

2008-06-30

0.49

2008-03-31

0.77

2007-12-31

0.46

2007-09-30

1.25

2007-06-30

2.03

2007-03-31

4.19

2006-12-31

1.69

2006-09-30

3.65

2006-06-30

3.40

2006-03-31

4.05

2005-12-31

6.62

2005-09-30

7.13

2005-06-30

1.66

2005-03-31

3.20

2004-12-31

4.57

2004-09-30

5.04

2004-06-30

14.24

2004-03-31

13.09

2003-12-31

8.06

2003-09-30

0.35

2003-06-30

0.49

2003-03-31

1.13

2002-12-31

0.30

2002-09-30

0.91

Quick Ratio (Acid-Test): 3.72

TGTX Quick Ratio

TGTX Average Quick Ratio (Acid-Test) Chart

TGTX Current vs Average Quick Ratio (Acid-Test) Chart

TGTX Quick Ratio (Acid-Test) Metrics

TGTX Competitors' Quick Ratio (Acid-Test)

Liquidity Comparison

Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio (Acid-Test) FAQ

TGTX Quick Ratio (Acid-Test) History

Related Metrics